Share: Facebook Twitter LinkedIn
Activity Provided By:

Integritas Communications

ASCVD Clinical Research Updates Targeting Residual Inflammation in Patients with ASCVD and CKD

Access Activity

Overview / Abstract:

Emerging evidence and scientific advancements are revealing pathophysiologic mechanisms correlated with systemic inflammation and the development of atherosclerotic cardiovascular disease (ASCVD). Patients with chronic kidney disease (CKD) are at high risk for developing ASCVD. Novel anti-inflammatory therapies are showing efficacy at reducing inflammation and development of ASCVD, and are adding to the treatment options beyond the usual lipid-lowering agents. As new clinical evidence and targeted therapies emerge, cardiologists, nephrologists, and other clinicians who care for patients with CKD need to stay up to date on the changing treatment paradigm for reducing risk of ASCVD. During this Clinical Research Updates™ activity, our expert faculty share cardiology and nephrology perspectives and insights into how best to incorporate these new and emerging treatments in busy clinical practices worldwide. This forward-looking CME program aims to capture expert interpretations of new and emerging therapies for reducing systemic inflammation, including the published evidence to support them, to help cardiologists, nephrologists, and other clinicians reduce the risk of development of ASCVD in their patients living with CKD.

Expiration

Aug 30, 2025

Format

Online, Webinar / Webcast / Video

Credits / Hours

1.0

Accreditation

ACCME

Presenters / Authors / Faculty

Paul M. Ridker, MD, MPH
Eugene Braunwald Professor of Medicine, Harvard Medical School
Director, Center for Cardiovascular Disease Prevention
Physician, Brigham and Women’s Hospital
Boston, Massachusetts

Katherine R. Tuttle, MD, FASN, FACP, FNKF
Executive Director for Research
Providence Inland Northwest Health
Professor of Medicine
University of Washington
Spokane, Washington

Sponsors / Supporters / Grant Providers

This activity is provided by Integritas Communications.

This activity is supported by an educational grant from Novo Nordisk, Inc.

Keywords / Search Terms

Integritas Communications ASCVD, cardiology, nephrology Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map